A New Horizon of Atopic Dermatitis Therapy Course
A New Horizon of Atopic Dermatitis Therapy Course is organized by American Academy of Allergy Asthma & Immunology (AAAAI).
Course opens: 08/25/2022
Course expires: 07/31/2024
Description:
Patients with atopic dermatitis struggle with ongoing challenges when trying to manage this chronic condition. Their symptoms can be disruptive, and some treatments can cause new problems for them to handle. Patients with skin of color often face unique challenges caused by missed diagnoses and negative side effects of traditional treatments. New therapeutic agents, including biologics and JAK inhibitors, can help these patients to manage their symptoms without the negative side effects they have experienced with other treatments, but appropriate use of these new therapies presents its own set of challenges. A New Horizon of Atopic Dermatitis Therapy was designed by a multidisciplinary team of allergist/immunologists, dermatologists, advanced practitioners, and patients to help allergist/immunologists and dermatologists, as well as advanced practitioners and nurses working in these clinical settings, to support their patients with atopic dermatitis to navigate the new treatment options that are now available, while incorporating patients and their quality of life concerns in the process of selecting the best therapy for each patient. This course will take approximately two and one-half hours to complete. Then, after a 30 day wait period, you will be invited to complete a follow-up assessment that will qualify you to satisfy the practice improvement requirement of the ABAI's Maintenance of Certification program.
Learning Objectives:
Upon completion of this activity, participants should be able to:
• Determine the appropriate treatment for patients with AD
• Evaluate the risks and benefits of biologics of JAK inhibitors, including their mechanisms of action, when be used in the treatment and care of patients with AD
• Identify opportunities to engage the patient in developing a treatment plan for AD that addresses their unique circumstances, including quality of life and socioeconomic factors
